BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36871351)

  • 1. Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer.
    Rezaeian AH; Phan LM; Zhou X; Wei W; Inuzuka H
    Neoplasia; 2023 Apr; 38():100890. PubMed ID: 36871351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regulatory effect of Skp2 on the expression and transactivation of the androgen receptor in the progression of castration-resistant prostate cancer].
    Song YT; Wu KJ; Wang XY; Na YG; Yin CM
    Zhonghua Nan Ke Xue; 2016 Feb; 22(2):122-7. PubMed ID: 26939395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skp2 deficiency restricts the progression and stem cell features of castration-resistant prostate cancer by destabilizing Twist.
    Ruan D; He J; Li CF; Lee HJ; Liu J; Lin HK; Chan CH
    Oncogene; 2017 Jul; 36(30):4299-4310. PubMed ID: 28346424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2.
    Kokontis JM; Lin HP; Jiang SS; Lin CY; Fukuchi J; Hiipakka RA; Chung CJ; Chan TM; Liao S; Chang CH; Chuu CP
    PLoS One; 2014; 9(10):e109170. PubMed ID: 25271736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylation-dependent regulation of Skp2 function.
    Inuzuka H; Gao D; Finley LW; Yang W; Wan L; Fukushima H; Chin YR; Zhai B; Shaik S; Lau AW; Wang Z; Gygi SP; Nakayama K; Teruya-Feldstein J; Toker A; Haigis MC; Pandolfi PP; Wei W
    Cell; 2012 Jul; 150(1):179-93. PubMed ID: 22770219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p300-Mediated Acetylation of Histone Demethylase JMJD1A Prevents Its Degradation by Ubiquitin Ligase STUB1 and Enhances Its Activity in Prostate Cancer.
    Xu S; Fan L; Jeon HY; Zhang F; Cui X; Mickle MB; Peng G; Hussain A; Fazli L; Gleave ME; Dong X; Qi J
    Cancer Res; 2020 Aug; 80(15):3074-3087. PubMed ID: 32522824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.
    Chuu CP; Kokontis JM; Hiipakka RA; Fukuchi J; Lin HP; Lin CY; Huo C; Su LC; Liao S
    Cancer Sci; 2011 Nov; 102(11):2022-8. PubMed ID: 21781227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer.
    Yu C; Wu G; Li R; Gao L; Yang F; Zhao Y; Zhang J; Zhang R; Zhang J; Yao L; Yuan J; Li X
    Cancer Biol Ther; 2015; 16(2):287-96. PubMed ID: 25756511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer.
    Li B; Lu W; Yang Q; Yu X; Matusik RJ; Chen Z
    Prostate; 2014 Apr; 74(4):421-32. PubMed ID: 24347472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
    Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
    Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
    Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skp2 suppresses p53-dependent apoptosis by inhibiting p300.
    Kitagawa M; Lee SH; McCormick F
    Mol Cell; 2008 Feb; 29(2):217-31. PubMed ID: 18243116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavokawain B targets protein neddylation for enhancing the anti-prostate cancer effect of Bortezomib via Skp2 degradation.
    Li X; Pham V; Tippin M; Fu D; Rendon R; Song L; Uchio E; Hoang BH; Zi X
    Cell Commun Signal; 2019 Mar; 17(1):25. PubMed ID: 30885218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
    Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
    Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear receptor ERRĪ± contributes to castration-resistant growth of prostate cancer via its regulation of intratumoral androgen biosynthesis.
    Xu Z; Ma T; Zhou J; Gao W; Li Y; Yu S; Wang Y; Chan FL
    Theranostics; 2020; 10(9):4201-4216. PubMed ID: 32226548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade.
    Mickova A; Kharaishvili G; Kurfurstova D; Gachechiladze M; Kral M; Vacek O; Pokryvkova B; Mistrik M; Soucek K; Bouchal J
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.
    Ruscetti M; Dadashian EL; Guo W; Quach B; Mulholland DJ; Park JW; Tran LM; Kobayashi N; Bianchi-Frias D; Xing Y; Nelson PS; Wu H
    Oncogene; 2016 Jul; 35(29):3781-95. PubMed ID: 26640144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of dihydrotestosterone-inactivation activity promotes prostate cancer castration resistance detectable by functional imaging.
    Zhu Z; Chung YM; Sergeeva O; Kepe V; Berk M; Li J; Ko HK; Li Z; Petro M; DiFilippo FP; Lee Z; Sharifi N
    J Biol Chem; 2018 Nov; 293(46):17829-17837. PubMed ID: 30262668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgens repress expression of the F-box protein Skp2 via p107 dependent and independent mechanisms in LNCaP prostate cancer cells.
    Jiang J; Pan Y; Regan KM; Wu C; Zhang X; Tindall DJ; Huang H
    Prostate; 2012 Feb; 72(2):225-32. PubMed ID: 21630295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer.
    Culig Z
    J Cell Physiol; 2016 Feb; 231(2):270-4. PubMed ID: 26201947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.